Foley Hoag Represents Thermo Fisher Scientific in Acquiring Max Analytical Technologies
March 15, 2022
Foley Hoag LLP represented Thermo Fisher Scientific Inc. (NYSE: TMO), a world leader in serving science, in acquiring Max Analytical Technologies, a producer of FTIR-based gas analysis solutions for process monitoring. The acquisition complements and expands Thermo Fisher’s FTIR instrument, software, and service offerings, and expands the breadth of vibrational spectroscopy solutions and services across a range of market segments.
Thermo Fisher is the world leader in serving science, with annual revenue of approximately $35 billion. The company’s mission is to enable its customers to make the world healthier, cleaner and safer. Thermo Fisher’s global team of more than 90,000 colleagues delivers a combination of innovative technologies, purchasing convenience and pharmaceutical services through its industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.
Foley Hoag attorneys Joe Basile, Shaida Mirmazaheri, Luciano Racco, Earl Mellott, Aaron Lang, Ian Chasse Osborn, Robert Haney Jr., Sarah Nyaeme, Erik Huestis and Jonathan Keselenko represented Thermo Fisher Scientific in the transaction.
About Foley Hoag LLP
Foley Hoag provides innovative, strategic legal services to public, private and government clients across the globe. We have premier capabilities in the life sciences, healthcare, technology, energy, professional services and private funds fields, and in cross-border disputes. The diverse backgrounds, perspectives and experiences of our lawyers and business services professionals contribute to the exceptional service we deliver to clients ranging from startups to multinational companies to sovereign states. For more information, visit www.foleyhoag.com or follow @FoleyHoag on Twitter.